Please login to the form below

Not currently logged in
Email:
Password:

Boyds expands regulatory affairs team

Céline Courtay-Cahen joins the pharma and biotech consultancy

Boyd Consultants Celine Courtay-CahenBoyd Consultants has appointed Céline Courtay-Cahen as a regulatory affairs consultant, based out of its Cambridge, UK office.

In her new role, Courtay-Cahen will manage projects including orphan drug designations, clinical trial applications and marketing authorisation applications.

She joins the consultancy from Evigo Pharma Consulting, where she also served as a regulatory affairs consultant and worked on a number of gene therapy projects, paediatric products, and in pharmacovigilance.

Prior to this, Courtay-Cahen worked in a various research positions with roles at the Institute of Structural Biology in Grenoble, the faculty of medicine at the Free University of Brussels, and the department of pathology at the University of Cambridge.

Alan Boyd, founder and chief executive officer of Boyd Consultants, said: “I am delighted to welcome Céline to our team at this exciting time. Her expertise will complement that of the team adding more value to our clients.”

17th June 2016

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics